TF and neoplasm: As NANOG can be induced by HIF and cytokines including interleukin-6 [1, 35], tumor microenvironments such as hypoxia and inflammation may (epigenetically) reprogram non-CSCs to the CSC state through NANOG by similarly antagonizing/engaging lineage-specific TF signaling complexes.